Literature DB >> 25952527

Irisin, an exercise-induced myokine as a metabolic regulator: an updated narrative review.

Ning Chen1, Qingxue Li2,3, Jun Liu1, Shaohui Jia1.   

Abstract

Irisin, as a new hormone-like myokine, is discovered in the presence of exercise-induced peroxisome proliferator-activated receptor gamma coactivator-1-alpha (PGC-1α). Which substance plays an important role in energy metabolism in each organ in the body and the regulation of metabolic diseases such as obesity and diabetes. The finding of irisin can contribute to the exploration of the novel and effective therapeutic targets or therapeutic strategies of these metabolic diseases or metabolism-associated health issues. To date, little is known regarding the functions and regulatory mechanisms of irisin with respect to metabolic diseases or metabolism-associated health issues. In this narrative review article, we systematically introduce its structural characteristics, production and distribution in tissues and organs, and the regulation and corresponding mechanisms for metabolic diseases or metabolism-associated health issues of irisin. Meanwhile, its future prospects and the development of irisin-related products for the promotion of human health have also been proposed, which will benefit future research and application of irisin.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  diabetes; exercise; irisin; metabolic disease; myokine; obesity

Mesh:

Substances:

Year:  2015        PMID: 25952527     DOI: 10.1002/dmrr.2660

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  29 in total

Review 1.  Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome.

Authors:  Tara McDonnell; Leanne Cussen; Marie McIlroy; Michael W O'Reilly
Journal:  Ther Adv Endocrinol Metab       Date:  2022-07-18       Impact factor: 4.435

2.  Serum Irisin Levels and Clinical Implication in Elderly Patients With Type 2 Diabetes Mellitus.

Authors:  Xianfa Xuan; Jincheng Lin; Yiqin Zhang; Lina Zhou; Liping Xu; Junlu Jia; Benhua Zhao; Zhiyang Lin; Qiong Zhu; Lianmeng Li; Ting Wu; Siyu Zhang; Hanxiang Jiang; Yuxin Wang
Journal:  J Clin Med Res       Date:  2020-08-15

Review 3.  Irisin: linking metabolism with heart failure.

Authors:  Jiamin Li; Susu Xie; Lei Guo; Jun Jiang; Han Chen
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

4.  Voluntary stand-up physical activity enhances endurance exercise capacity in rats.

Authors:  Dae Yun Seo; Sung Ryul Lee; Hyo-Bum Kwak; Kyo Won Seo; Robin A McGregor; Ji Young Yeo; Tae Hee Ko; Saranhuu Bolorerdene; Nari Kim; Kyung Soo Ko; Byoung Doo Rhee; Jin Han
Journal:  Korean J Physiol Pharmacol       Date:  2016-04-26       Impact factor: 2.016

5.  Exercise-induced irisin release as a determinant of the metabolic response to exercise training in obese youth: the EXIT trial.

Authors:  Devin R Blizzard LeBlanc; Brittany V Rioux; Cody Pelech; Teri L Moffatt; Dustin E Kimber; Todd A Duhamel; Vernon W Dolinsky; Jonathan M McGavock; Martin Sénéchal
Journal:  Physiol Rep       Date:  2017-12

6.  FNDC5/irisin - their role in the nervous system and as a mediator for beneficial effects of exercise on the brain.

Authors:  Christiane D Wrann
Journal:  Brain Plast       Date:  2015

7.  Irisin Recovers Osteoarthritic Chondrocytes In Vitro.

Authors:  Gianluca Vadalà; Giuseppina Di Giacomo; Luca Ambrosio; Francesca Cannata; Claudia Cicione; Rocco Papalia; Vincenzo Denaro
Journal:  Cells       Date:  2020-06-17       Impact factor: 6.600

8.  A Review on the Role of Irisin in Insulin Resistance and Type 2 Diabetes Mellitus.

Authors:  Mamo Gizaw; Pandi Anandakumar; Tolessa Debela
Journal:  J Pharmacopuncture       Date:  2017-10-10

9.  The Alteration of Irisin-Brain-Derived Neurotrophic Factor Axis Parallels Severity of Distress Disorder in Bronchial Asthma Patients.

Authors:  Magdolna E Szilasi; Krisztian Pak; Laszlo Kardos; Viktoria E Varga; Ildiko Seres; Angela Mikaczo; Andrea Fodor; Maria Szilasi; Gabor Tajti; Csaba Papp; Rudolf Gesztelyi; Judit Zsuga
Journal:  Front Neurosci       Date:  2017-11-23       Impact factor: 4.677

10.  Cardiometabolic Effects of Irisin in Patients with End-Stage Renal Disease on Regular Hemo- or Peritoneal Dialysis.

Authors:  Botond Csiky; Balázs Sági; Vanessza Emmert; István Wittmann; Endre Sulyok
Journal:  Blood Purif       Date:  2021-08-02       Impact factor: 3.348

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.